Lauren Bor - TC BioPharm Head Division
| TCBPW Stock | USD 0.02 0 24.67% |
Executive
Lauren Bor is Head Division of TC BioPharm plc
| Address | Maxim 1, Motherwell, United Kingdom, ML1 4WR |
| Phone | 44 14 1433 7557 |
| Web | https://tcbiopharm.com |
TC BioPharm Management Efficiency
The company has return on total asset (ROA) of (1.0892) % which means that it has lost $1.0892 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.1748) %, meaning that it generated substantial loss on money invested by shareholders. TC BioPharm's management efficiency ratios could be used to measure how well TC BioPharm manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.75 in 2024. Return On Capital Employed is likely to drop to -3.58 in 2024. At this time, TC BioPharm's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 3.6 M in 2024, whereas Total Current Assets are likely to drop slightly above 5.2 M in 2024.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Eva Gunnlaugsdottir | Alvotech Warrant | N/A | |
| RoseMarie Ohlsson | Alvotech Warrant | N/A | |
| Dallas Coleman | bioAffinity Technologies Warran | N/A | |
| Yafit Tehila | Inspira Technologies Oxy | 41 | |
| Sandra Casaca | Alvotech Warrant | N/A | |
| Adi Nir | Inspira Technologies Oxy | N/A | |
| Tanya Zharov | Alvotech Warrant | 57 | |
| Daniella YeheskelyHayon | Inspira Technologies Oxy | 47 | |
| Jenny Steingrimsdottir | Alvotech Warrant | N/A | |
| Giedrius Zunda | Alvotech Warrant | N/A | |
| William Bauta | bioAffinity Technologies Warran | N/A | |
| Meshira Greenberg | Inspira Technologies Oxy | N/A | |
| Christina Siniscalchi | Alvotech Warrant | N/A | |
Management Performance
| Return On Equity | -12.17 | ||||
| Return On Asset | -1.09 |
TC BioPharm plc Leadership Team
Elected by the shareholders, the TC BioPharm's board of directors comprises two types of representatives: TC BioPharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TCBPW. The board's role is to monitor TC BioPharm's management team and ensure that shareholders' interests are well served. TC BioPharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TC BioPharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA, CoFounder Chairman | ||
| Lauren Bor, Head Division | ||
| Martin Thorp, CFO Director | ||
| Christopher Camarra, Executive Communications | ||
| Bryan Kobel, CEO Director | ||
| Angela Scott, CoFounder COO |
TCBPW Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TC BioPharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.